Standard
OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden. / Grøn, K.l.; Arkema, E.; Glintborg, B.; Mehnert, F.; Østergaard, M.; Dreyer, L.; Nørgaard, M.; Krogh, N.s.; Askling, J.; Heltand, M.
2018. 208-208.
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › fagfællebedømt
Harvard
Grøn, KL, Arkema, E
, Glintborg, B, Mehnert, F, Østergaard, M, Dreyer, L, Nørgaard, M, Krogh, NS, Askling, J & Heltand, M 2018, '
OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden', s. 208-208.
https://doi.org/10.1136/annrheumdis-2018-eular.2389APA
Grøn, K. L., Arkema, E.
, Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J., & Heltand, M. (2018).
OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden. 208-208.
https://doi.org/10.1136/annrheumdis-2018-eular.2389Vancouver
Grøn KL, Arkema E
, Glintborg B, Mehnert F, Østergaard M, Dreyer L o.a..
OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden. 2018.
https://doi.org/10.1136/annrheumdis-2018-eular.2389Author
Grøn, K.l. ; Arkema, E. ; Glintborg, B. ; Mehnert, F. ; Østergaard, M. ; Dreyer, L. ; Nørgaard, M. ; Krogh, N.s. ; Askling, J. ; Heltand, M. / OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden. 1 s.
Bibtex
@conference{3d0cd90a341143b39676bce1f471bb10,
title = "OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden",
author = "K.l. Gr{\o}n and E. Arkema and B. Glintborg and F. Mehnert and M. {\O}stergaard and L. Dreyer and M. N{\o}rgaard and N.s. Krogh and J. Askling and M. Heltand",
year = "2018",
doi = "10.1136/annrheumdis-2018-eular.2389",
language = "English",
pages = "208--208",
}
RIS
TY - ABST
T1 - OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden
AU - Grøn, K.l.
AU - Arkema, E.
AU - Glintborg, B.
AU - Mehnert, F.
AU - Østergaard, M.
AU - Dreyer, L.
AU - Nørgaard, M.
AU - Krogh, N.s.
AU - Askling, J.
AU - Heltand, M.
PY - 2018
Y1 - 2018
U2 - 10.1136/annrheumdis-2018-eular.2389
DO - 10.1136/annrheumdis-2018-eular.2389
M3 - Conference abstract for conference
SP - 208
EP - 208
ER -
